Grant: CIHR Fellowship
McGill University
$135,000.00
Determining the role of CCN3 in promoting breast cancer metastasis to bone
EF 2009-10
Résumé
Breast cancer is the most frequent and the second most lethal cancer affecting woman in Canada. When the tumor remains confined to the breast, patients have a good prognosis following surgery. The most devastating aspect of this disease is the emergence of tumor cells that are capable of spreading or "metastasizing" to other organs and tissues. The skeleton is a common site for breast cancer metastasis; however, the reasons for this are not fully understood. We have used mouse models to isolate breast cancer cell lines that aggressively metastasize to bone and have compared them to cells that are weakly bone metastatic. In this way, we have identified several candidates, including the protein CCN3 (Nov), which are expressed at higher levels in the aggressively bone metastatic cells versus those that are weakly bone metastatic. The aim of my research will be to determine if CCN3 plays a causal role in promoting breast cancer metastasis to bone. We have verified that our cells both express and secrete the CCN3 protein. We also have demonstrated that CCN3 inhibits osteoblast differentiation and favors osteoclast differentiation, two cell types that are found in bone and play a role in the formation of bone metastases. We are presently investigating if CCN3 expression can influence the formation of bone metastasis using mouse models. Finally, we will evaluate CCN3 expression in breast tumors and bone metastases from human-derived samples. We wish to determine if factors, such as CCN3, which are identified using animal models are relevant to the human disease and could prove to be diagnostic markers or potential therapeutic targets that may improve our ability to manage breast cancer bone metastasis.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
203066
Name
Ouellet Veronique
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Not applicable / Specified
Prcname2
Fellowships - Post-PhD
Projecttitle
Determining the role of CCN3 in promoting breast cancer metastasis to bone
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bone Metastasis; Breast Cancer; Ccn Proteins; Cdna Microarray; Elisa; Human Tissues; Immunohistocytochemistry; Mouse Model; Osteoblast Osteoclast Differentiation; Real-Time Pcr
Abstract
Breast cancer is the most frequent and the second most lethal cancer affecting woman in Canada. When the tumor remains confined to the breast, patients have a good prognosis following surgery. The most devastating aspect of this disease is the emergence of tumor cells that are capable of spreading or "metastasizing" to other organs and tissues. The skeleton is a common site for breast cancer metastasis; however, the reasons for this are not fully understood. We have used mouse models to isolate breast cancer cell lines that aggressively metastasize to bone and have compared them to cells that are weakly bone metastatic. In this way, we have identified several candidates, including the protein CCN3 (Nov), which are expressed at higher levels in the aggressively bone metastatic cells versus those that are weakly bone metastatic. The aim of my research will be to determine if CCN3 plays a causal role in promoting breast cancer metastasis to bone. We have verified that our cells both express and secrete the CCN3 protein. We also have demonstrated that CCN3 inhibits osteoblast differentiation and favors osteoclast differentiation, two cell types that are found in bone and play a role in the formation of bone metastases. We are presently investigating if CCN3 expression can influence the formation of bone metastasis using mouse models. Finally, we will evaluate CCN3 expression in breast tumors and bone metastases from human-derived samples. We wish to determine if factors, such as CCN3, which are identified using animal models are relevant to the human disease and could prove to be diagnostic markers or potential therapeutic targets that may improve our ability to manage breast cancer bone metastasis.
Competitiondate
201002
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ouellet, Veronique
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~